G Medical Innovations

Mobility in Health care

Founded 2014

Austin, United States 35 employees Post-IPO Equity Total: $40.90M Health Care, Medical Devices

G Medical Innovations “Nasdaq: GMVD” is a next-generation mobile health company. We believe in transforming personal healthcare by developing innovative mobile-health solutions that provide comprehensive, medical-grade diagnostics using remote and personalized platforms. Founded in 2014, we strive to increase healthcare efficiency, empower physicians, caregivers and consumers, and improve personal quality of life by providing a higher level of healthcare that is accessible to more people worldwide. G Medical Innovations operates in the USA, Europe, China, the Middle East and Australia. The Company has established a new and advanced manufacturing site in China, Guangdong, and operates a wholly owned subsidiary, G Medical Diagnostic Services, Inc. that provides arrhythmia monitoring and diagnostics in the USA. The G Medical PRIZMA offering is an innovative FDA cleared/CE approved medical smartphone case that transforms any smartphone into a medical monitoring and diagnostic device. With PRIZMA, users can independently manage their health by continuously measuring, monitoring and sharing vital signs with caregivers and loved ones. A further offering in development, the Vital Monitoring System (VSMS) with G Medical Patch (GMP) is a health monitoring solution that provides accurate diagnostics in real-time and offers a heightened level of care for patient monitoring in all healthcare settings. This modular, easy-to-use, clinical grade solution utilizes patented wireless technologies, proprietary information technology and service platforms. The solutions can enhance patient care and help healthcare providers increase efficiency, decrease liability and reduce the number of readmissions. (Note: The GMP/VSMS device is currently under CE and FDA evaluation and it is not for sale in the US)

Funding Stage	Amount	Investors	Date
Post IPO Equity	$500.00K	-	25 Oct 2023
Post IPO Equity	$9.60M	-	31 Mar 2023
Post IPO Equity	$20.50M	-	09 Dec 2019
Post IPO Equity	$10.30M	-	16 Nov 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Post IPO Equity

$500.00K

25 Oct 2023

Post IPO Equity

$9.60M

31 Mar 2023

Post IPO Equity

$20.50M

09 Dec 2019

Post IPO Equity

$10.30M

16 Nov 2017

FAQ About G Medical Innovations

Mobility in Health care

G Medical Innovations was founded in 2014.

G Medical Innovations is headquartered in Austin, United States.

G Medical Innovations operates in Health Care and Medical Devices.

G Medical Innovations has approximately 35 employees.

G Medical Innovations has completed 4 funding rounds, raising a total of $40.90M. The latest funding stage is Post-IPO Equity.

Top alternatives and competitors to G Medical Innovations include BioIntelliSense, Inc, iMEDRIX INC., Carematix Inc., Scanwell Health, iXensor. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

G Medical Innovations and BioIntelliSense, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About G Medical Innovations

Funding Rounds & Investors (4)

G Medical Innovations Alternatives & Competitors

FAQ About G Medical Innovations